Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Targets Trust XXIV TARGETS 7%INTC
TOI | US
0.36
USD-0.01
-2.73%
TOI | US
About Targets Trust XXIV TARGETS 7%INTC
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.36
Open
0.37
High
0.38
Low
0.34
The Oncology Institute Inc. an oncology company provides various medical oncology services in the United States. The company operates in three segments: Dispensary Patient Services and Clinical Trials & Other. It offers physician services in-house infusion and dispensary clinical trial services radiation outpatient blood product transfusions and patient support services. The company also offers and manages clinical trial services such as managing clinical trials palliative care programs and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute Inc. was founded in 2007 and is headquartered in Cerritos California.
View LessTOI | US
Risk
48.1
Sharpe
-0.82
Luna's Score
40/100
Recommendation
Sell
Luna says (TOI | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
56.6%1 month
48.1%3 months
103.1%6 months
97.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.96
Debt to equity
4.14
Debt to assets
0.67
Ent. to EBITDA
-1.87
Ent. to rev.
0.28
PEG
-
Other Fundamentals
EBITDA
-57.34M
MarketCap
27.17M
MarketCap(USD)
27.17M
Div. yield
-
Op. margin
-16.60
Erngs. growth
-
Rev. growth
22.90
Ret. on equity
-125.59
Short ratio
2.58
Short perc.
0.51
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.08
Range1M
0.11
Range3M
0.31
Volumes: Market Activity
Rel. volume
2.00
Price X volume
45.50K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.87 | 13.85 | Cheaper |
| Ent. to Revenue | 0.28 | 1.73 | Cheaper |
| PE Ratio | - | 22.94 | - |
| Price to Book | 0.96 | 14.91 | Cheaper |
| Dividend Yield | - | 1.25 | - |
| Std. Deviation (3M) | 103.05 | 51.88 | Riskier |
| Debt to Equity | 4.14 | 5.15 | Par |
| Debt to Assets | 0.67 | 0.46 | Expensive |
| Market Cap | 27.17M | 6.67B | Emerging |
